News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–144
Matches
409
Sources here
15
Companies here
7
Search results Stored financial headlines

Active search

409 matching headlines

Ticker or company: CIRMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Circle Internet Group vs. Salesforce: Which Technology Stock Is a Better Buy in 2026?

Investors choosing between high-growth fintech and established software giants face a unique dilemma. Should you bet on Circle Internet Group (NYSE:CRCL) or the proven cloud dominance of Salesforce (NYSE:CRM)? Circle provides the infrastructure for digital dollars, while Salesforce offers a comprehensive suite of customer …

CRCL main company
Sharemaestro market context Price below Trend Line 52 weeks -47.0% CRCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Circle Internet Group (CRCL) director sells 20,000 shares at $61.65 average

Danita K. Ostling, a director at Circle Internet Group, Inc. (CRCL), sold 20,000 shares of Class A common stock on August 6, 2026, at a weighted average price of $61.65 per share. Following this transaction, her direct holdings in the company amount to 4,608 …

CRCL main company
Sharemaestro market context Price below Trend Line 52 weeks -47.0% CRCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Circle Internet Group (NYSE: CRCL) CEO sells 62,264 shares in plan

Circle Internet Group (NYSE: CRCL) Chairman and CEO Jeremy Allaire reported the sale of 62,264 Class A shares on August 5, 2026, through a Rule 10b5-1 trading plan. These shares were sold in multiple transactions at weighted-average prices between $60.14 and $63.66. Following these …

CRCL main company
Sharemaestro market context Price below Trend Line 52 weeks -47.0% CRCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Press Release: Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pacira BioSciences announced inducement grants of stock options and restricted stock units (RSUs) to seven new employees. These grants, totaling 19,850 stock options and 11,000 RSUs, were made outside the company's existing equity incentive plans as an inducement material to the new hires' employment …

PCRX main company
Sharemaestro market context Trend signal active 52 weeks -11.0% PCRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cirrus Logic to Present at Upcoming Conference

AUSTIN, Texas, August 07, 2026--(BUSINESS WIRE)--Cirrus Logic, Inc. (Nasdaq: CRUS)announced that Chief Financial Officer Jeff Woolard and Executive Vice President of Mixed-Signal Products Carl Alberty will present at the KeyBanc Technology Leadership Forum in Deer Valley, Utah on August 11, 2026 at 11:30 a.m. …

CRUS main company
Sharemaestro market context Price below Trend Line 52 weeks +3.2% CRUS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Analysts Offer Insights on NA Companies: Circle Internet Group, Inc. Class A (CRCL), Regal Rexnord (RRX) and Lineage, Inc. (LINE)

This article provides analyst insights on three NA sector companies: Circle Internet Group, Inc. Class A (CRCL), Regal Rexnord (RRX), and Lineage, Inc. (LINE). Deutsche Bank maintained a Hold rating on CRCL, while also maintaining a Buy rating on RRX. Truist Financial maintained a …

CRCL main company
Sharemaestro market context Price below Trend Line 52 weeks -47.0% CRCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bernstein says Circle investors are focusing on wrong risks

Research and brokerage firm Bernstein says that investors worried about the Circle Internet Group (NYSE: CRCL) are fixating on the wrong concerns, and that the stablecoin issuer's latest results make the case against the skeptics. In a note to clients on Aug. 6, analysts …

CRCL main company
Sharemaestro market context Price below Trend Line 52 weeks -47.0% CRCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Here's What Analysts Are Forecasting For Pacira BioSciences, Inc. (NASDAQ:PCRX) After Its Second-Quarter Results

This article examines the latest analyst forecasts for Pacira BioSciences, Inc. (NASDAQ:PCRX) following its second-quarter results. It provides an overview of the consensus earnings estimates and how they have changed over time, along with an assessment of the company's financial performance and future prospects …

PCRX main company
Sharemaestro market context Trend signal active 52 weeks -11.0% PCRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CRCL (CRCL) insider plans sale of 20,000 Class A shares after vesting

Danita Ostling, an insider at CRCL (Circle Internet Group, Inc.), has filed to sell up to 20,000 Class A shares through Fidelity Brokerage Services, with an estimated value of $1,232,940.81. This proposed sale follows prior restricted stock vesting events, including 19,230 shares on June …

CRCL main company
Sharemaestro market context Price below Trend Line 52 weeks -47.0% CRCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

The $667.7 Million Question: What Happens When Stablecoin Reserve Income Gets Competed Away

Circle renewed its revenue-sharing agreement with Coinbase on August 5, locking in a distribution model that cost the issuer approximately $908 million in fiscal year 2024. The following day, CoinShares published a research note identifying the Open USD (OUSD) consortium as an existential threat …

CRCL main company
Sharemaestro market context Price below Trend Line 52 weeks -47.0% CRCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Jabil Stock And 2 More US Import Dependent Companies Tied To Tariff Refunds

The Supreme Court's ruling on tariff refunds for import-heavy corporations has made trade policy more dynamic for investors. This article highlights three US large-cap, import-dependent companies—Plexus (PLXS), Benchmark Electronics (BHE), and Jabil (JBL)—that are particularly sensitive to these changes. It analyzes how potential tariff …

JBL main company
Sharemaestro market context Trend signal active 52 weeks +73.2% · Next-week setup positive 57.0% JBL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Cathie Wood isn't having a great year. Just one of Ark Invest's six actively managed exchange-traded funds (ETFs) is beating the market, and its largest ETF is currently in the red year to date. However, the founder, CEO, and chief investment officer at Ark …

CRCL main company
Sharemaestro market context Price below Trend Line 52 weeks -47.0% CRCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CIRRUS LOGIC, INC. 2026: Revenue $459.72M, EPS $1.47— 10-Q Summary

CIRRUS LOGIC, INC. (CRUS) reported strong financial results for the quarter ended 2026, with revenue increasing by 12.9% to $459.72M and diluted EPS rising 28.9% to $1.47 compared to the prior year. The growth was primarily driven by higher smartphone component shipments and strong …

CRUS main company
Sharemaestro market context Price below Trend Line 52 weeks +3.2% CRUS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Record Q1 FY27 results at Cirrus Logic (NASDAQ: CRUS) with $459.7M revenue

Cirrus Logic reported record first-quarter fiscal 2027 results, with revenue of $459.7 million, marking a two percent sequential and thirteen percent year-over-year increase, driven by strong smartphone component demand. The company achieved GAAP diluted EPS of $1.47 and non-GAAP diluted EPS of $1.84. For …

CRUS main company
Sharemaestro market context Price below Trend Line 52 weeks +3.2% CRUS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pacira BioSciences, Inc. $PCRX Shares Purchased by Pacer Advisors Inc.

Pacer Advisors Inc. increased its stake in Pacira BioSciences, Inc. by 24.5% in the first quarter, now owning 235,427 shares. The company reported strong Q2 revenue and EPS, exceeding analyst expectations, but its 2026 revenue guidance fell below consensus. Analyst sentiment is mixed, with …

PCRX main company
Sharemaestro market context Trend signal active 52 weeks -11.0% PCRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cirrus Logic (NASDAQ: CRUS) grows Q1 sales and flags major IRS tax case

Cirrus Logic (NASDAQ: CRUS) reported strong first-quarter fiscal 2027 results with net sales up 13% to $459.7 million, driven by demand for audio and high-performance mixed-signal products in smartphones. The company also disclosed an ongoing IRS tax dispute from 2017–2019, with the IRS proposing …

CRUS main company
Sharemaestro market context Price below Trend Line 52 weeks +3.2% CRUS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Analysts Offer Insights on NA Companies: Versigent Limited (VGNT), SpaceX (SPCX) and Circle Internet Group, Inc. Class A (CRCL)

This article highlights bullish sentiments from analysts on three NA sector companies: Versigent Limited (VGNT), SpaceX (SPCX), and Circle Internet Group, Inc. Class A (CRCL). Analysts from Morgan Stanley, Wolfe Research, William Blair, RBC Capital, and TD Cowen have reiterated or initiated Buy ratings …

CRCL main company
Sharemaestro market context Price below Trend Line 52 weeks -47.0% CRCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

Pacira BioSciences announced the publication of positive two-year results from its Phase 1 clinical trial for PCRX-201, an investigational gene therapy for knee osteoarthritis, in the Annals of the Rheumatic Diseases. The study found that a single intra-articular injection of PCRX-201 was well-tolerated and …

PCRX main company
Sharemaestro market context Trend signal active 52 weeks -11.0% PCRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Jabil Surges 31.6% in Past Six Months: Reason to Buy the Stock Now?

Jabil (JBL) has seen a significant 31.6% stock surge in the last six months, driven by its strong position in the AI and machine learning ecosystem, diversified product portfolio, and diligent operational execution. The company's photonics-based optical transceiver modules, developed with Intel's technology, are …

JBL main company
Sharemaestro market context Trend signal active 52 weeks +73.2% · Next-week setup positive 57.0% JBL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Funding Circle launches a new mobile app, giving FlexiPay and Card customers greater financial control and on the go flexibility

LONDON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Funding Circle, the UK’s leading SME finance platform, today launches its new mobile application (“app”). Designed to provide a seamless customer experience, the latest app provides small businesses with a fast, intuitive, and centralised platform to manage …

FCH main company
Sharemaestro market context Trend signal active 52 weeks +65.7% FCH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pacira BioSciences, Inc. Stock 12‑Month Price Target Raised to $30, Implies 9% Upside

Pacira BioSciences, Inc.'s stock price target has been raised to $30 from $29.67 by 6 analysts, suggesting a 9% potential upside from its August 4 closing price. The consensus rating for PCRX remains a "Buy," with a breakdown of 3 Buys, 2 Holds, and …

PCRX main company
Sharemaestro market context Trend signal active 52 weeks -11.0% PCRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cirrus Logic cites smartphone demand after record $460M quarter

Cirrus Logic (NASDAQ: CRUS) announced record first-quarter fiscal year 2027 revenue of $459.7 million, driven by strong demand for custom components in smartphones. The company also reported progress in its PC business with interest in smart codecs for AI-enabled PCs and taped out a …

CRUS main company
Sharemaestro market context Price below Trend Line 52 weeks +3.2% CRUS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Circle’s USDC volume jumps 151%, but revenue tells different story

Circle Internet Group (CRCL) issues USDC, a stablecoin designed to maintain a value of $1. The company earns most of its revenue from interest on the reserve assets backing the USDC in circulation. Circle said USDC onchain transaction volume reached $14.8 trillion during the …

CRCL main company
Sharemaestro market context Price below Trend Line 52 weeks -47.0% CRCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

JBL4934570 Bond Profile — Key Metrics

This article provides a bond profile for Jabil Inc.'s JBL4934570 bond, detailing key metrics such as its 3.6% coupon rate and maturity date of January 15, 2030. It also outlines Jabil Inc.'s business operations through its Electronics Manufacturing Services (EMS) and Diversified Manufacturing Services …

JBL main company
Sharemaestro market context Trend signal active 52 weeks +73.2% · Next-week setup positive 57.0% JBL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Circle Internet Group Q2 2026 Earnings Call Summary

Circle Internet Group Q2 2026 Earnings Call Summary - Moby Strategic Execution and Network Expansion Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

CRCL main company
Sharemaestro market context Price below Trend Line 52 weeks -47.0% CRCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cirrus Logic slips on revenue miss despite earnings beat

Cirrus Logic (NASDAQ:CRUS) reported mixed first-quarter fiscal 2027 results, beating earnings expectations with $1.84 adjusted EPS but missing revenue estimates with $459.7 million, sending shares down 4.1%. The company saw record Q1 revenue and EPS, driven by strong demand for smartphone components, and provided …

CRUS main company
Sharemaestro market context Price below Trend Line 52 weeks +3.2% CRUS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pacira BioSciences (NASDAQ: PCRX) earns Q2 profit and sells iovera business

Pacira BioSciences (NASDAQ: PCRX) reported a profit in Q2 2026 with total revenues of $192.4 million, driven by strong sales of EXPAREL and ZILRETTA. The company also announced the divestiture of its iovera° cryoanalgesia business to Zimmer for up to $140 million, including an …

PCRX main company
Sharemaestro market context Trend signal active 52 weeks -11.0% PCRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cirrus Logic, Inc. 2027 Q1 - Results - Earnings Call Presentation (NASDAQ:CRUS)

This article presents the slide deck published by Cirrus Logic, Inc. for their 2027 Q1 earnings call, held on August 5, 2026. The company reported EPS of $1.84, beating estimates by $0.03, and revenue of $459.72M, a 12.88% year-over-year increase, though it missed estimates …

CRUS main company
Sharemaestro market context Price below Trend Line 52 weeks +3.2% CRUS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Jabil (JBL) director N. V. Tyagarajan purchases 500 shares at 299.6299

Jabil Inc. director N. V. Tyagarajan purchased 500 shares of Jabil common stock at a price of $299.6299 per share on July 17, 2026. This open market transaction increased his direct holdings to 3,464 shares. The purchase, valued at approximately $150,000, was reported in …

JBL main company
Sharemaestro market context Trend signal active 52 weeks +73.2% · Next-week setup positive 57.0% JBL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pacira BioSciences Q2 Earnings Call Highlights

Pacira BioSciences reported a 6% increase in Q2 2026 revenue to $192.4 million, driven by strong sales of EXPAREL, ZILRETTA, and iovera°. The company highlighted expanded payer coverage for EXPAREL and progress in its pipeline, while also completing the sale of iovera° to Zimmer …

PCRX main company
Sharemaestro market context Trend signal active 52 weeks -11.0% PCRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pacira BioSciences (PCRX) Advances PCRX 201 As Its Undervalued Narrative Faces A Fresh Test

Pacira BioSciences (PCRX) has advanced its osteoarthritis gene therapy candidate, PCRX-201, to a scalable U.S. commercial manufacturing process and has begun enrolling patients in Part B of the Phase 2 ASCEND study. The company's shares are currently trading at US$26.92, which is significantly below …

PCRX main company
Sharemaestro market context Trend signal active 52 weeks -11.0% PCRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context